PCDHB15 and melanoma: Here, we evaluated whether the treatment with the demethylation agent, 5azadC, at low doses reverts PCDHB15 silencing, as we have shown that 5azadC treatment at low doses reverted melanoma cell invasion in 3D invasion assays and in vivo metastasis formation [20].